Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05636332 · ClinicalTrials.gov registry record · NA
The Intrepid Clinical Engineering Study
A NA study of Sudden Cardiac Arrest, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05636332: Completed NA study of Sudden Cardiac Arrest, sponsored by Philips Clinical & Medical Affairs Global.
NCT05636332 is a NA study of Sudden Cardiac Arrest that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 60 participants, below the 1,827-participant average among 8 other Sudden Cardiac Arrest trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05636332, a NA study of Sudden Cardiac Arrest, has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to collect clinical data to validate a software update for 12-lead electrocardiogram monitoring.
Primary Outcome
Number of participants with failure to obtain a 12-lead Electrocardiogram (ECG) with the Philips HeartStart Intrepid Monitor/Defibrillator.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST 12 lead Electrocardiogram
Study Locations (1)
Florida
- Lehigh Pulmonary Associates, PA (D/B/A Florida Lung & Sleep Associates) - Lehigh Acres
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-10-03 |
| Est. Completion | 2022-11-02 |
| Phase | NA |
What the finished NCT05636332 record still lists
NCT05636332 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,827-participant average among 8 other Sudden Cardiac Arrest trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Sudden Cardiac Arrest appearing as the primary indexed condition, and to 1 intervention - of which 12 lead Electrocardiogram is the first listed.
NCT05636332 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05636332 about?
NCT05636332 is a clinical study titled "The Intrepid Clinical Engineering Study". The purpose of this research study is to collect clinical data to validate a software update for 12-lead electrocardiogram monitoring.
What is the current status of trial NCT05636332?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-10-03. Estimated completion is 2022-11-02.
What conditions does trial NCT05636332 study?
This clinical trial studies the following conditions: Sudden Cardiac Arrest.
What interventions are being tested in trial NCT05636332?
The interventions under investigation include: 12 lead Electrocardiogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05636332?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05636332 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sudden Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05636332's enrollment target sits among peer trials
60 8th of 8 higher than 1 of 8 other Sudden Cardiac Arrest trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sudden Cardiac Arrest trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Combined CCM and ICD Device in HFrEF
ACTIVE NOT RECRUITING · NA
-
Feasibility Study of Remote Support for Implantable Pulse Generator (IPG)/Implantable Cardioverter Defibrillator (ICD) Implant
COMPLETED · NA
-
HeartStart HS1 Defibrillator* Event Registry
RECRUITING
-
HS Students Mandatory Universal Student Instruction in CPR Appraised Learning- Is the Mandate Working?
RECRUITING
-
HeartStart FRx Defibrillator Event Registry
RECRUITING
-
Mayo AVC Registry and Biobank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI